Manchester Paediatric Haematologist set for London To Paris Cycle

27th May 2022


Rob Wynn, a Consultant Paediatric Haematologist based in Manchester, who has seen at first hand the incredible and continuing impact that Cure Leukaemia has had in research in this area, is getting on his bike to show his support for the charity.

Rob is gearing up to tackle Cure Leukaemia’s London To Paris cycle in June to help raise funds for the charity’s pioneering Trials Acceleration Programme (TAP) Network.


He’ll join over 130 cyclists tackling the 478km (320 miles) challenge to cycle from London to Paris over 4 days in June.

“I am a keen cyclist, I do a lot of cycling, so I’m hoping I will be fine throughout the London to Paris cycle.

I did an event in the Lake District last week which was 112 miles across all of the Lake District passes and I didn’t get off, so I’m counting that as a win!

I am getting on in years now, so I am hoping that I am going to be able to keep up with the young ones across the four days!”


Rob is Director of the Blood and Marrow Transplant (BMT) Unit in the Royal Manchester Children’s Hospital and Honorary Professor of Clinical Paediatric Haematology and Cellular Therapy.

He grew up in Liverpool and is an avid fan of Liverpool Football Club – and will be cheering on the Reds in the Champions League Final at the weekend. He completed his undergraduate medical training in Cambridge and The London, while he completed his post graduate training in Newcastle and Edinburgh and Haematology and Transplant training in Manchester and Toronto.

“Cure Leukaemia is a vibrant organisation that is deeply embedded in the scientific, clinical and patient community with reaches into sport, football and cycling. They have a track record of achievement and ambition.

“With those roots and those ambitions, I think we can be optimisitic that Cure Leukaemia will make a difference to the everyday lives of people living with blood cancer across the country and I can’t wait to do my bit to help!”

You can help support Rob’s fundraising by donating online via his JustGiving page here.

 

< Back to List

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell